Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation

References

• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2019. CA Cancer J Clin . 2019;69(1):7–34. doi:10.3322/caac.21551 30620402
   PubMed Web of Science ®Google Scholar
• Howlader N , Forjaz G , Mooradian MJ , et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med . 2020;383(7):640–649. doi:10.1056/NEJMoa1916623 32786189
   PubMed Web of Science ®Google Scholar
• Ward EM , Sherman RL , Henley SJ , et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20–49 Years. J Natl Cancer Inst . 2019;111(12):1279–1297. doi:10.1093/jnci/djz106 31145458
   PubMedGoogle Scholar
• Liang G , Meng W , Huang X , et al. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer. Proc Natl Acad Sci U S A . 2020;117(8):4347–4357. doi:10.1073/pnas.1917531117 32041891
   PubMed Web of Science ®Google Scholar
• Lin S , Gregory RI . MicroRNA biogenesis pathways in cancer. Nat Rev Cancer . 2015;15(6):321–333. doi:10.1038/nrc3932 25998712
   PubMed Web of Science ®Google Scholar
• Dambal S , Shah M , Mihelich B , Nonn L . The microRNA-183 cluster: the family that plays together stays together. Nucleic Acids Res . 2015;43(15):7173–7188. doi:10.1093/nar/gkv703 26170234
   PubMed Web of Science ®Google Scholar
• Ning FL , Wang F , Li ML , Yu ZS , Hao YZ , Chen SS . MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagn Pathol . 2014;9(1):143. doi:10.1186/1746-1596-9-143 25012722
   PubMed Web of Science ®Google Scholar
• Wang M , Wang Y , Zang W , et al. Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. Tumour Biol . 2014;35(1):39–46. doi:10.1007/s13277-013-1004-8 23877371
   PubMedGoogle Scholar
• Chang H , Liu YH , Wang LL , et al. MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer. Am J Transl Res . 2018;10(4):1131–1142.29736206
   PubMed Web of Science ®Google Scholar
• Wang M , Wang W , Wang J , Zhang J . MiR-182 promotes glucose metabolism by upregulating hypoxia-inducible factor 1alpha in NSCLC cells. Biochem Biophys Res Commun . 2018;504(2):400–405. doi:10.1016/j.bbrc.2018.06.035 29894685
   PubMed Web of Science ®Google Scholar
• Yang WB , Chen PH , Hsu T , et al. Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget . 2014;5(3):740–753. doi:10.18632/oncotarget.1608 24519909
   PubMedGoogle Scholar
• Zou JG , Ma LF , Li X , et al. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer. Eur Rev Med Pharmacol Sci . 2019;23(3):1108–1115. doi:10.26355/eurrev_201902_17001 30779079
   PubMed Web of Science ®Google Scholar
• Zhu W , Zhou K , Zha Y , et al. Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small Cell lung cancer. PLoS One . 2016;11(4):e0153046. doi:10.1371/journal.pone.0153046 27093275
   PubMed Web of Science ®Google Scholar
• Zhu W , Liu X , He J , Chen D , Hunag Y , Zhang YK . Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study. BMC Cancer . 2011;11(1):393. doi:10.1186/1471-2407-11-393 21920043
   PubMed Web of Science ®Google Scholar
• Peng Z , Pan L , Niu Z , et al. Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis. Oncotarget . 2017;8(38):64143–64156. doi:10.18632/oncotarget.19358 28969058
   PubMedGoogle Scholar
• Xu F , Zhang H , Su Y , Kong J , Yu H , Qian B . Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. Clin Trans Oncol . 2014;16(11):980–985. doi:10.1007/s12094-014-1183-9
   PubMed Web of Science ®Google Scholar
• Kozomara A , Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res . 2014;42(D1):D68–73. doi:10.1093/nar/gkt1181 24275495
   PubMed Web of Science ®Google Scholar
• Anaya J . OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci . 2016;2(2):e67. doi:10.7717/peerj-cs.67
   Google Scholar
• Wang S , Zhao X , Wang J , et al. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer. Medical Oncol . 2013;30(3):681. doi:10.1007/s12032-013-0681-x
   PubMed Web of Science ®Google Scholar
• Vosa U , Vooder T , Kolde R , et al. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Genes Chromosomes Cancer . 2011;50(10):812–822. doi:10.1002/gcc.20902 21748820
   PubMed Web of Science ®Google Scholar
• Yuan D , Li K , Zhu K , Yan R , Dang C . Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer. Cancer Biol Ther . 2015;16(2):268–275. doi:10.1080/15384047.2014.1002327 25629978
   PubMed Web of Science ®Google Scholar
• Huangfu L , Liang H , Wang G , et al. miR-183 regulates autophagy and apoptosis in colorectal cancer through targeting of UVRAG. Oncotarget . 2016;7(4):4735–4745. doi:10.18632/oncotarget.6732 26717041
   PubMedGoogle Scholar
• Lowery AJ , Miller N , Dwyer RM , Kerin MJ . Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer . 2010;10(1):502. doi:10.1186/1471-2407-10-502 20858276
   PubMed Web of Science ®Google Scholar
• Vosa U , Vooder T , Kolde R , Vilo J , Metspalu A , Annilo T . Meta-analysis of microRNA expression in lung cancer. Int J Cancer . 2013;132(12):2884–2893. doi:10.1002/ijc.27981 23225545
   PubMed Web of Science ®Google Scholar
• Myatt SS , Wang J , Monteiro LJ , et al. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res . 2010;70(1):367–377. doi:10.1158/0008-5472.CAN-09-1891 20028871
   PubMed Web of Science ®Google Scholar
• Chen L , Li Y , Fu Y , et al. Role of deregulated microRNAs in breast cancer progression using FFPE tissue. PLoS One . 2013;8(1):e54213. doi:10.1371/journal.pone.0054213 23372687
   PubMed Web of Science ®Google Scholar
• Han Y , Chen J , Zhao X , et al. MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One . 2011;6(3):e18286. doi:10.1371/journal.pone.0018286 21464941
   PubMed Web of Science ®Google Scholar
• Bandres E , Cubedo E , Agirre X , et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer . 2006;5(1):29. doi:10.1186/1476-4598-5-29 16854228
   PubMed Web of Science ®Google Scholar
• Schaefer A , Jung M , Mollenkopf HJ , et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer . 2010;126(5):1166–1176. doi:10.1002/ijc.24827 19676045
   PubMed Web of Science ®Google Scholar
• Zheng WW , Huang CM , Xie JW , et al. [Expression of microRNA-183 in stage II (gastric cancer and its association with Ezrin protein]. Zhonghua Wei Chang Wai Ke Za Zhi . 2012;15(7):723–726. Chinese.22851079
   PubMedGoogle Scholar
• Li J , Liang S , Jin H , Xu C , Ma D , Lu X . Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncol Rep . 2012;27(6):1835–1842. doi:10.3892/or.2012.1744 22469921
   PubMed Web of Science ®Google Scholar
• Mian C , Pennelli G , Fassan M , et al. MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid . 2012;22(9):890–896. doi:10.1089/thy.2012.0045 22747440
   PubMed Web of Science ®Google Scholar
• Yamada Y , Enokida H , Kojima S , et al. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci . 2011;102(3):522–529. doi:10.1111/j.1349-7006.2010.01816.x 21166959
   PubMed Web of Science ®Google Scholar
• Zhu J , Feng Y , Ke Z , et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol . 2012;180(6):2440–2451. doi:10.1016/j.ajpath.2012.02.023 22525461
   PubMed Web of Science ®Google Scholar
• Zhang L , Quan H , Wang S , Li X , Che X . MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Tumour Biol . 2015;36(10):8121–8126. doi:10.1007/s13277-015-3550-8 25983004
   PubMedGoogle Scholar
• Meng F , Zhang L . miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition. Exp Cell Res . 2019;374(2):315–322. doi:10.1016/j.yexcr.2018.12.003 30528264
   PubMed Web of Science ®Google Scholar
• Li Y , He S , Zhan Y , et al. microRNA-183-3p inhibits progression of human prostate cancer by downregulating high-mobility group nucleosome binding domain 5. DNA Cell Biol . 2019;38(8):840–848. doi:10.1089/dna.2019.4642 31314587
   PubMed Web of Science ®Google Scholar
• Zhang C , Lian H , Xie L , Yin N , Cui Y . LncRNA ELFN1-AS1 promotes esophageal cancer progression by up-regulating GFPT1 via sponging miR-183-3p. Biol Chem . 2020;401(9):1053–1061. doi:10.1515/hsz-2019-0430 32229685
   PubMed Web of Science ®Google Scholar
• Li Z , Yu Y , Lu J , et al. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol . 2009;4(6):702–709. doi:10.1097/JTO.0b013e3181a5269d 19404215
   PubMed Web of Science ®Google Scholar
• Zhao H , Chen W , Wu J , Wang L , Mao W . Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma. J Cancer Res Ther . 2014;10 Suppl:C179–185. doi:10.4103/0973-1482.145863 25450279
   PubMed Web of Science ®Google Scholar
• Wu J , Xu H , Ji H , et al. Low expression of keratin17 is related to poor prognosis in bladder cancer. Onco Targets Ther . 2021;14:577–587. doi:10.2147/OTT.S287891 33500631
   PubMed Web of Science ®Google Scholar
• Meng C , Guo Z , Li D , et al. miR-183 and miR-141 in lesion tissues are potential risk factors for poor prognosis in patients with infected abdominal aortic aneurysm. Exp Ther Med . 2018;16(6):4695–4699. doi:10.3892/etm.2018.6733 30542422
   PubMed Web of Science ®Google Scholar